Last edition
News about "pre-filled syringe "
Teva Pharma Launches AHZANTIVE Biosimilar to Eylea in Europe
Teva has launched AHZANTIVE (aflibercept), an EMA-approved biosimilar to Eylea, across Europe. Demonstrating comparable efficacy, safety, and immunogenicity to the reference product, the launch expands Teva’s biosimilars and ophthalmology portfolio while supporting its long-term Pivot to Growth strategy.
Pre-filled Syringe | 06/06/2026 | By News Bureau
WuXi Biologics' Wuxi Facilities Receive MHRA GMP Approval for Ophthalmic Biologic Manufacturing
The UK regulator has certified WuXi Biologics’ DP5 and DPPC sites in Wuxi for commercial production, reinforcing the company’s global GMP-compliant manufacturing capabilities.
Pre-Filled Syringe | 13/01/2026 | By News Bureau | 243
INCOG Facility Receives FDA Approval for Commercial Drug Production
INCOG BioPharma Services has announced that its sterile injectable manufacturing facility has received approval from the US Food and Drug Administration (FDA) to produce a commercially approved drug product.
Pre-filled Syringe | 01/05/2024 | By Aishwarya | 628
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy